| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2025 | Feb 25, 2025 | ImmunityBio, Inc. | CEO | Sell | 20.0 | -78,167 | -18.95% | ✗ | $267.3K |
| Dec 31, 2024 | Jan 3, 2025 | ImmunityBio, Inc. | CEO | Sell | 26.3 | -17,475 | -6.29% | ✗ | $44.7K |
| Feb 5, 2024 | Feb 6, 2024 | ImmunityBio, Inc. | CEO | Sell | 22.5 | -43,165 | -15.08% | ✗ | $174.4K |
| Dec 31, 2023 | Jan 3, 2024 | ImmunityBio, Inc. | CEO | Sell | 22.5 | -17,096 | -7.77% | ✗ | $85.8K |
| Feb 5, 2023 | Feb 7, 2023 | ImmunityBio, Inc. | CEO | Sell | 22.5 | -42,192 | -18.52% | ✗ | $182.7K |
| Dec 31, 2022 | Jan 4, 2023 | ImmunityBio, Inc. | CEO | Sell | 26.3 | -4,273 | -2.87% | ✗ | $21.7K |
| Feb 5, 2022 | Feb 8, 2022 | ImmunityBio, Inc. | CEO | Sell | 22.5 | -29,415 | -17.16% | ✗ | $158.5K |
| Oct 8, 2021 | Oct 8, 2021 | ImmunityBio, Inc. | CEO | Buy | 78.8 | +1,930 | 2.24% | ✗ | $17K |
| Sep 9, 2021 | Sep 13, 2021 | ImmunityBio, Inc. | CEO | Sell | 26.3 | -4,273 | -4.72% | ✗ | $42.5K |
| Feb 5, 2021 | Feb 9, 2021 | ImmunityBio, Inc. | CEO | Sell | 17.5 | -68,171 | -45.45% | ✗ | $1.6M |